XOMA Corporation (XOMA)
NASDAQ: XOMA
· Real-Time Price · USD
25.18
0.06 (0.24%)
At close: May 22, 2025, 3:59 PM
25.11
-0.28%
After-hours: May 22, 2025, 04:04 PM EDT
Company Description
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific.
The company engages in helping biotech companies for enhancing human health.
It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies.
The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners.
It has a portfolio with approximately 70 assets.
XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
XOMA Corporation
| Country | United States |
| IPO Date | Jun 6, 1986 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 13 |
| CEO | Owen P. Hughes Jr. |
Contact Details
Address: 2200 Powell Street EmeryVille, California United States | |
| Website | https://www.xoma.com |
Stock Details
| Ticker Symbol | XOMA |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000791908 |
| CUSIP Number | 98419J206 |
| ISIN Number | US98419J2069 |
| Employer ID | 52-2154066 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Owen P. Hughes Jr. | Chief Executive Officer & Director |
| Thomas M. Burns | Senior Vice President of Finance & Chief Financial Officer |
| Bradley Sitko | Chief Investment Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 21, 2025 | 4 | Filing |
| May 21, 2025 | 4 | Filing |
| May 20, 2025 | 4 | Filing |
| May 20, 2025 | SCHEDULE 13D/A | [Amend] Filing |
| May 13, 2025 | 10-Q | Quarterly Report |
| May 13, 2025 | 8-K | Current Report |
| May 07, 2025 | SCHEDULE 13G | Filing |
| Apr 15, 2025 | ARS | Filing |
| Apr 15, 2025 | DEF 14A | Filing |
| Apr 09, 2025 | 4 | Filing |